Filing status
- Accounts due
- 30 September 2027
- Last accounts
- 31 December 2025
- Conf. stmt due
- 27 January 2027
- Last conf. stmt
- 13 January 2026
Thorpe Laboratories Limited
- Incorporated
- 18 June 2003 (23 years)
- Industry
- Manufacture of pharmaceutical preparations (21200)
- Owned by
- Accounts type
- Audit exemption subsidiary
- Region
- South East
- Address
- Key HouseSarum HillBasingstokeRG21 8SR
Charges
- Total
- 3
- Outstanding
- 2
- Part satisfied
- 0
- Satisfied
- 1
Officers 3 active
Officer details are public data from the Companies House register.
Director · Appointed 23 December 2021
British
Born December 1989 (36)
Director · Appointed 23 December 2021
British
Born November 1965
Director · Appointed 23 December 2021
British
Born August 1991 (35)
Officer history (7 former)
23 December 2021
23 December 2021
23 December 2021
23 December 2021
23 December 2021
19 December 2009
Resigned Sabin, John Arthur as Director
30 June 2008
Resigned Williams, Stephen John as Director
21 March 2006
Resigned Snowden, Colin John as Director
18 June 2004
Appointed Sabin, John Arthur as Director
18 June 2004
Appointed Williams, Stephen John as Director
18 June 2004
Appointed Snowden, Colin John as Director
18 July 2003
18 July 2003
18 July 2003
18 July 2003
18 June 2003
18 June 2003
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Corporate entity · Notified 23 December 2021
Owns 75–100% of shares
Holds 75–100% of voting rights
Right to appoint and remove directors
Private Limited Company
Reg. no. 07117426
Former controllers (1)
23 December 2021
Group structure 6 companies
Ownership group derived from the Companies House PSC register
Crescent Manufacturing Limited Owns 75–100% of shares
Crescent Medical UK Limited Owns 75–100% of shares
Crescent Pharma Limited Owns 75–100% of shares
Crescent Pharma Otc Limited Owns 75–100% of shares
Thorpe Laboratories Limited This company Owns 75–100% of shares
Financials
Figures from 2021 accounts. Newer accounts, made up to 31 December 2025, are filed but not read yet. See them on Companies House
- Net Assets
- (£214,707)
- up £831,806 (79%)
- Cash
- £0
- down £408 (100%)
- Employees
- 25
- down 3 (11%)
- Debt Ratio
- 156%
- Current Ratio
- 0.6x
Trend
Net Assets
Balance sheet detail
| 2021 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|
| Fixed Assets | £46,284 | £45,594 | £49,943 | £55,961 |
| Current Assets | £339,669 | £271,489 | £254,782 | £442,109 |
| Debtors | £244,616 | £112,495 | £99,471 | £193,522 |
| Cash | £0 | £408 | £412 | £412 |
| Creditors (< 1 year) | £562,578 | £1,319,780 | £450,851 | £601,651 |
| Creditors (> 1 year) | £38,082 | £43,816 | £1,291,311 | £1,363,289 |
| Net Current Assets | (£222,909) | (£1,048,291) | (£196,069) | (£159,542) |
| Net Assets | (£214,707) | (£1,046,513) | (£1,437,437) | (£1,466,870) |
| Shareholder Funds | (£214,707) | (£1,046,513) | (£1,437,437) | (£1,466,870) |
Filings
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 22 October 2026 | Other filing | |||
| 22 October 2026 | Other filing | |||
| 22 October 2026 | Accounts filing | |||
| 22 October 2026 | Audit exemption subsidiary accounts | 31 December 2025 | ||
| 14 January 2026 | Confirmation statement with no updates | 13 January 2026 |
Some other companies at this address
Other companies in this industry
Oxford
Castleford
Runcorn
Northampton
By trade and location
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →